The AA Composition of CGMP (Lacprodan CGMP-20) and Whey Protein (Lacprodan DI-9224) and the Amounts of AAs Received by a 300-g Rat at a Dose of 1500 mg/kg
. | CGMP . | Whey Protein . | ||
---|---|---|---|---|
Composition (%) . | Dose for 300-g rat (mg) . | Composition (%) . | Dose for 300-g rat (mg) . | |
Alanine | 6.6 | 29.7 | 5.6 | 25.2 |
Arginine | 0.3 | 1.4 | 2.2 | 9.9 |
Apartate | 3.4 | 15.3 | 11.5 | 5.2 |
Asparagine | 2.2 | 9.9 | ||
Glutamate | 12.2 | 54.9 | 18.6 | 8.4 |
Glutamine | 2.8 | 12.6 | ||
Cysteine | 0.1 | 0.5 | 2.5 | 11.3 |
Glycine | 1.2 | 5.4 | 1.7 | 7.7 |
Histidine | 0.1 | 0.5 | 1.8 | 8.1 |
Isoleucine | 11.3 | 50.9 | 7.1 | 32.0 |
Leucine | 2.4 | 10.8 | 11.5 | 51.8 |
Lysine | 6.6 | 29.7 | 10.3 | 46.4 |
Methionine | 2.2 | 9.9 | 2.5 | 11.3 |
Phenylalanine | 0.2 | 0.9 | 3.2 | 14.4 |
Proline | 12.8 | 57.6 | 6.9 | 31.1 |
Serine | 8.1 | 36.5 | 5.2 | 23.4 |
Threonine | 18.3 | 82.4 | 7.7 | 34.7 |
Tryptophan | 0.1 | 0.5 | 1.8 | 8.1 |
Tyrosine | 0.0 | 0.1 | 3.1 | 14.0 |
Valine | 9.1 | 41.0 | 6.3 | 28.4 |
. | CGMP . | Whey Protein . | ||
---|---|---|---|---|
Composition (%) . | Dose for 300-g rat (mg) . | Composition (%) . | Dose for 300-g rat (mg) . | |
Alanine | 6.6 | 29.7 | 5.6 | 25.2 |
Arginine | 0.3 | 1.4 | 2.2 | 9.9 |
Apartate | 3.4 | 15.3 | 11.5 | 5.2 |
Asparagine | 2.2 | 9.9 | ||
Glutamate | 12.2 | 54.9 | 18.6 | 8.4 |
Glutamine | 2.8 | 12.6 | ||
Cysteine | 0.1 | 0.5 | 2.5 | 11.3 |
Glycine | 1.2 | 5.4 | 1.7 | 7.7 |
Histidine | 0.1 | 0.5 | 1.8 | 8.1 |
Isoleucine | 11.3 | 50.9 | 7.1 | 32.0 |
Leucine | 2.4 | 10.8 | 11.5 | 51.8 |
Lysine | 6.6 | 29.7 | 10.3 | 46.4 |
Methionine | 2.2 | 9.9 | 2.5 | 11.3 |
Phenylalanine | 0.2 | 0.9 | 3.2 | 14.4 |
Proline | 12.8 | 57.6 | 6.9 | 31.1 |
Serine | 8.1 | 36.5 | 5.2 | 23.4 |
Threonine | 18.3 | 82.4 | 7.7 | 34.7 |
Tryptophan | 0.1 | 0.5 | 1.8 | 8.1 |
Tyrosine | 0.0 | 0.1 | 3.1 | 14.0 |
Valine | 9.1 | 41.0 | 6.3 | 28.4 |
For whey protein, the aspartate and asparagine values as well as the glutamate and glutamine values are combined.
The AA Composition of CGMP (Lacprodan CGMP-20) and Whey Protein (Lacprodan DI-9224) and the Amounts of AAs Received by a 300-g Rat at a Dose of 1500 mg/kg
. | CGMP . | Whey Protein . | ||
---|---|---|---|---|
Composition (%) . | Dose for 300-g rat (mg) . | Composition (%) . | Dose for 300-g rat (mg) . | |
Alanine | 6.6 | 29.7 | 5.6 | 25.2 |
Arginine | 0.3 | 1.4 | 2.2 | 9.9 |
Apartate | 3.4 | 15.3 | 11.5 | 5.2 |
Asparagine | 2.2 | 9.9 | ||
Glutamate | 12.2 | 54.9 | 18.6 | 8.4 |
Glutamine | 2.8 | 12.6 | ||
Cysteine | 0.1 | 0.5 | 2.5 | 11.3 |
Glycine | 1.2 | 5.4 | 1.7 | 7.7 |
Histidine | 0.1 | 0.5 | 1.8 | 8.1 |
Isoleucine | 11.3 | 50.9 | 7.1 | 32.0 |
Leucine | 2.4 | 10.8 | 11.5 | 51.8 |
Lysine | 6.6 | 29.7 | 10.3 | 46.4 |
Methionine | 2.2 | 9.9 | 2.5 | 11.3 |
Phenylalanine | 0.2 | 0.9 | 3.2 | 14.4 |
Proline | 12.8 | 57.6 | 6.9 | 31.1 |
Serine | 8.1 | 36.5 | 5.2 | 23.4 |
Threonine | 18.3 | 82.4 | 7.7 | 34.7 |
Tryptophan | 0.1 | 0.5 | 1.8 | 8.1 |
Tyrosine | 0.0 | 0.1 | 3.1 | 14.0 |
Valine | 9.1 | 41.0 | 6.3 | 28.4 |
. | CGMP . | Whey Protein . | ||
---|---|---|---|---|
Composition (%) . | Dose for 300-g rat (mg) . | Composition (%) . | Dose for 300-g rat (mg) . | |
Alanine | 6.6 | 29.7 | 5.6 | 25.2 |
Arginine | 0.3 | 1.4 | 2.2 | 9.9 |
Apartate | 3.4 | 15.3 | 11.5 | 5.2 |
Asparagine | 2.2 | 9.9 | ||
Glutamate | 12.2 | 54.9 | 18.6 | 8.4 |
Glutamine | 2.8 | 12.6 | ||
Cysteine | 0.1 | 0.5 | 2.5 | 11.3 |
Glycine | 1.2 | 5.4 | 1.7 | 7.7 |
Histidine | 0.1 | 0.5 | 1.8 | 8.1 |
Isoleucine | 11.3 | 50.9 | 7.1 | 32.0 |
Leucine | 2.4 | 10.8 | 11.5 | 51.8 |
Lysine | 6.6 | 29.7 | 10.3 | 46.4 |
Methionine | 2.2 | 9.9 | 2.5 | 11.3 |
Phenylalanine | 0.2 | 0.9 | 3.2 | 14.4 |
Proline | 12.8 | 57.6 | 6.9 | 31.1 |
Serine | 8.1 | 36.5 | 5.2 | 23.4 |
Threonine | 18.3 | 82.4 | 7.7 | 34.7 |
Tryptophan | 0.1 | 0.5 | 1.8 | 8.1 |
Tyrosine | 0.0 | 0.1 | 3.1 | 14.0 |
Valine | 9.1 | 41.0 | 6.3 | 28.4 |
For whey protein, the aspartate and asparagine values as well as the glutamate and glutamine values are combined.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.